Clinical Trial Update: Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

View source ↗

Summary

Completed observational study in Germany evaluating the real-world efficacy and safety of NovoSeven (recombinant activated factor VII) for congenital and acquir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Hemophilia
• Congenital Factor Vii Deficiency
• Glanzmann Thrombasthenia

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Congenital FVII Deficiency | Status: COMPLETED